Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FDA Recommends CytoDyn Conduct Its Type A Meeting in Writing with FDA Response Goal Date of September 4
https://www.cytodyn.com/newsroom/press-releases/detail/464/to-avoid-delay-the-fda-recommends-cytodyn-conduct-its-type
U.K.’s MHRA Accepts CytoDyn’s Request to Enroll in its Current Phase 3 Trial for COVID-19 Patients with Severe-to-Critical Symptoms.
https://www.cytodyn.com/newsroom/press-releases/detail/465/after-several-months-of-providing-requested-information
@daemon57:Not. I just mean more therapy, more better. Maybe all vaccines not fully working just like FLU vaccine. Covid-19 change frequently, like D614G. So more therapy can save more patients, maybe you, me, everyone.
Roche's IL-6 receptor blocker fails in Phase III
https://european-biotechnology.com/up-to-date/latest-news/news/roches-il-6-receptor-blocker-fails-in-phase-iii.html
F.D.A.Hold on Blood Plasma's Emergency Approval
https://www.nytimes.com/2020/08/19/us/politics/blood-plasma-covid-19.html
These Are Some of The Top Companies Racing to Develop a Pandemic Treatment.
(MENAFN - Baystreet.ca) The CV-19 pandemic shows no signs of slowing. To date, there are nearly 21 million cases, with 769,235 deaths. In the U.S., cases are up to 5.25 million. Brazil is up to 3.22 million. India is nearing 2.5 million. Russia is now up to 910,778. Meanwhile, the World Health Organization has warned the situation could get far worse, meaning we need treatment immediately. With the coronavirus showing no signs of cooling, some of the top companies racing to develop treatment, include R evive Therapeutics (CSE:RVV)(OTC:RVVTF), Moderna Inc. (NASDAQ:MRNA), Johnson & Johnson (NYSE:JNJ), Vaxart Inc. (NASDAQ:VXRT), and CytoDyn Inc. (OTC:CYDY).
CytoDyn Announces Clinically Significant Top-line Results from its Phase 2 Trial in Mild-to-Moderate COVID-19 Patients
https://finance.yahoo.com/news/cytodyn-announces-clinically-significant-top-131500914.html
BLA-type submission planned this month in U.K. for HIV combination therapy with 350 mg weekly dose
• COVID-19 Phase 2 topline report to be submitted for consideration of emergency approval of leronlimab for patients with mild-to-moderate symptoms to U.K. and other countries following submission to the U.S. FDA next week
https://www.marketscreener.com/CYTODYN-INC-163210/news/CytoDyn-Seeks-UK-Approval-of-Leronlimab-for-HIV-and-COVID-19-31076230/
168,000 to 182,000 total COVID-19 deaths the ensemble forecast predicts that will be reported by August 22 by CDC.
OC Woman Credits Experimental Antibody Drug Leronlimab for COVID-19 Recovery in UCLA
https://spectrumnews1.com/ca/la-west/coronavirus/2020/07/30/oc-woman-credits-experimental-antibody-drug-for-covid-19-recovery
Any suggestions for this stock? Thanks!
Baylor University Medical Center will be a clinical testing site for CytoDyn's investigational drug Leronlimab, which has been used in a number of patients with COVID-19 as part of two clinical trial applications that have been fast-tracked by the FDA.
131,480 deadths,2,996,098 confirmed. So crazy!!! More people will be dead if no therapy. Possible to everyone.
Coronavirus:Why surviving the virus may be just the beginning
https://www.bbc.com/news/53193835
Antivirals Rather Than Vaccines For COVID-19
https://seekingalpha.com/article/4357271-antivirals-rather-vaccines-for-covidminus-19
According to the Biologics License Application Acknowledgment Letter that CytoDyn (OTCQB:CYDY) received from the FDA, a PDUFA date may be announced on July 10.
Requesting copies of all emergency investigational new drug (IND / EIND) files granted to CytoDyn, Inc.'s drug Leronlimab in relation to treatment of patients with COVID-19.
https://search.fda.gov/search?utf8=%E2%9C%93&affiliate=fda1&query=leronlimab
maraviroc (Selzentry) is chemicals, not antibody.
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022128s000_ChemR.pdf
Common side effects of Selzentry include stomach pain, diarrhea, constipation, tiredness, lightheadedness or dizziness while standing, cold symptoms (stuffy nose, sneezing, cough, sore throat), sleep problems (insomnia), swelling, problems with urination, muscle or joint pain, or skin rash.
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution and Supply of Leronlimab for Treatment of COVID-19 in United States
“Having this distribution agreement in place ahead of the readout from CytoDyn’s COVID-19 clinical trials further emphasizes CytoDyn’s commitment to making leronlimab immediately available to patients based on the successful completion of its ongoing clinical trials,” said Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn. “We are particularly happy to be partnering with a company with the proven expertise, unparalleled commercial reach and stellar reputation of American Regent.”
“American Regent is looking forward to partnering with CytoDyn to provide COVID-19 patients rapid and efficient access to a potentially life-saving drug,” said Mr. Harsher Singh, American Regent’s Vice President and Chief Commercial Officer.
https://finance.yahoo.com/news/cytodyn-announces-execution-exclusive-agreement-221510705.html
A lot of people will be dead if no any effective therapy. Safety of Leronlimab is confirmed.
Easy to Quantify Global Market Size
$25.8B HIV
$1,316.9B COVID-19
CytoDyn's Rude Interruption
https://seekingalpha.com/article/4356732-cytodyns-rude-interruption
7.22 FIDELITY
Wow,6.95bid, 6.95ask ON FIDELITY.
Anyone contact law firm to Prosecute Citron Research?
If you suffered a loss on your CytoDyn investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/cytodyn-inc/.You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
https://finance.yahoo.com/news/law-offices-frank-r-cruz-200000584.html
CytoDyn is encouraged by the potential of leronlimab to positively influence the tumor microenvironment by inhibiting T-reg infiltration, conversion of M2 macrophages (protumor macrophages) into M1 macrophages (antitumor macrophages), decreasing tumor angiogenesis, and inhibiting metastasis through CCR5 overexpression.
CytoDyn is currently exploring the efficacy of leronlimab for several immuno-oncology indications, including metastatic triple-negative breast cancer, a mechanism of action basket trial for 22 solid tumors, and a Phase 2 combination therapy for metastatic colorectal cancer. The FDA has granted leronlimab Fast Track designation for metastatic triple-negative breast cancer.
More people will be dead if no any effective therapy for Covid-19 AND HIV.
28+ CATALYSTSSykes and others must be losing big time- how can anyone short a stock with MORE THAN 28 CATALYSTS?
1. 21 basket of cancers trial
2. HIV BLA - July10 acceptance
3. COVID 75 Patient Trial
4. COVID 390 Patient Trial
5. NASH Trial Started
6. MEXICO Covid Filing
7. UPLISTING from OTC
8. PEER REVIEWED Journal Article8. Samsung Production Deal
9. Investment Bank Contract
10. Dr.Yo Dr.Patterson, other prominent endorsements
$10.01!!! If leronlimab is the only therapy to save covid19 severe patients. The stock price is not high. Infected covid 19 now 10 million!!!!!Just so far, Maybe second wave on the way!
Yale infectious disease doctor weighs in on HIV drug’s promise for COVID-19 and mask safety
“This is an interesting drug, it’s one that I’m very interested to see more of what happens. It seems to block that cytokine storm and it seems to temper it down so that people can get through the viral infection and not have their own body attacking itself,” says Dr. Manisha Juthani, Yale Medicine Infectious Disease Specialist and Associate Professor at Yale School of Medicine.
The drug is undergoing trials at the Montefiore Health System in New York.
Yale infectious disease doctor weighs in on HIV drug’s promise for COVID-19 and mask safety.
https://www.wtnh.com/news/health/coronavirus/yale-infectious-disease-doctor-weighs-in-on-hiv-drugs-promise-for-covid-19-and-mask-safety/?source=leronlimab.news
Fidelity: Bid: 8.99, ask 9.00. Maybe $10 is coming. Good news is coming. God bless everyone!
effective drug=stock price bullish so far.
Maybe $8.30 today OMG. Small Covid-19 Phase 3 Trial for Severe and Critically Ill Patients
Yahoo:17,000 traded pre market already compared to 3500 Friday. This is going to be a Big day. $ 7.35 ASK on fidelity!
Is there new DDAmanda chart? thanks!
Maybe Leronlimab, the first sucessful therapy to prevent covid if covid 19 similar to HIV
This HIV/AIDS Specialist Explains Its Similarities — And Differences — To COVID-19
https://www.forbes.com/sites/coronavirusfrontlines/2020/04/22/this-hivaids-specialist-explains-its-similarities---and-differences---to-covid-19/#3e9558549f8d
Fidelity: Bid 6.91, Ask: 7.95.
CytoDyn and NIH of Mexico Complete Memorandum of Understanding to Conduct Small Covid-19 Phase 3 Trial for Severe and Critically Ill Patients
June 29, 2020 6:00am EDT
https://www.cytodyn.com/newsroom/press-releases/detail/441/cytodyn-and-nih-of-mexico-complete-memorandum-of
Revealed: Scars of Covid-19 could last for life as doctors warn of long-term damage to health
Healthy people, who were in their 40s and 50s when the virus struck, are now facing anxiety, chronic fatigue and disability for years
https://www.telegraph.co.uk/news/2020/06/22/revealed-scars-covid-19-could-last-life-doctors-warn-long-term/
Don't Forget Cytodyn's Other Prospects
https://seekingalpha.com/article/4355694-dont-forget-cytodyns-prospects
Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed
https://www.marketwatch.com/story/race-for-a-covid-19-vaccine-has-drug-makers-scaling-up-manufacturing-before-one-is-developed-2020-06-25?siteid=yhoof2&yptr=yahoo.
CYDY has hopeful therapy before vaccine success.